ACC-085

N/A

Report date: 2026/04/03 17:28:35
NME

Base Information

Drug NameACC-085
Drug Alias NameACC085ACC-085
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV-1 Capsid Protein inhibitors
TargetsHIV-1 Capsid Protein
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Aidea Pharmaceutical Group Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Aidea Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A